Science and Technology Science and Technology
Tue, March 25, 2025
Mon, March 24, 2025
Sun, March 23, 2025
Sat, March 22, 2025
Fri, March 21, 2025
Thu, March 20, 2025
Wed, March 19, 2025
Tue, March 18, 2025
Mon, March 17, 2025
Sun, March 16, 2025
[ Sun, Mar 16th ] - Insider
The ghosted generation
Sat, March 15, 2025
Fri, March 14, 2025

Expert says COVID-19 mRNA vaccine is 'safe and effective,' as Senate Bill 177 languishes


//science-technology.news-articles.net/content/2 .. and-effective-as-senate-bill-177-languishes.html
Published in Science and Technology on Monday, March 17th 2025 at 1:02 GMT by NKyTribune   Print publication without navigation

  • By Kushi Arora Kentucky Health News A bill that would have banned schools and workplaces from requiring a COVID-19 vaccine or any mRNA vaccine for student enrollment, employment, or medical treatment and would have made it illegal to give such vaccines to children died while waiting on a hearing in its assigned state legislative

The article from the NKyTribune discusses the ongoing debate surrounding Senate Bill 177 in Kentucky, which aims to ban the use of mRNA vaccines, including those for COVID-19. Dr. Paul Schulz, an expert in infectious diseases, argues that the mRNA vaccines are both safe and effective, countering misinformation and fear-mongering. He highlights that these vaccines have undergone rigorous testing and have been administered to millions worldwide with proven efficacy in reducing severe illness, hospitalization, and death from COVID-19. Despite this, the bill, which has been criticized for lacking scientific backing, remains stalled in the legislative process, reflecting broader national debates on vaccine mandates, personal freedoms, and public health policy. The article also touches on the broader implications of such legislation, including potential setbacks in public health efforts and the spread of vaccine hesitancy.

Read the Full NKyTribune Article at:
[ https://nkytribune.com/2025/03/expert-says-covid-19-mrna-vaccine-is-safe-and-effective-as-senate-bill-177-languishes/ ]

Publication Contributing Sources